Category Archive: announcement

Event: Improving Long Term Outcomes Research


On Tuesday, March 14 from 10-11 AM in Tilghman Auditorium, Dale Needham, MD, PhD and his research team will present the many FREE resources for conducting clinical research, funded by his National Heart Lung and Blood Institute R24 national infrastructure grant. This grant has created resources for clinical researchers conducting longitudinal follow-up studies, including: a database of common patient-reported and performance-based outcome measurements and standardized information about them; adaptable tools, templates, and manuals to maximize retention of research participants, including an interactive searchable database of >600 retention strategies; and a statistical tool to address “competing risk of mortality” when evaluating […]

Funding Opportunity: Nexus Award for Externships in Drug and Device Development


The Drugs, Biologics, Vaccines and Devices Translational Research Community of the Johns Hopkins Institute for Clinical and Translational Research is accepting applications for their Nexus Award Program.  The award strives to improve the research environment and career satisfaction of faculty by providing funds to investigators engaged in drugs, biologics, vaccines or device design. It is designed for investigators who wish to engage in short immersion experiences with colleagues at other academic research centers or industry partners. The award provides up to $25,000 including a maximum of $5,000 in travel, $200/day in support or replacement salary support. Applications are due on […]

Event: New Approaches to Metabolomics Research


Due to expected inclement weather, this event has been postponed. The Drugs, Biologics, Vaccines and Devices Translational Research Community of the Johns Hopkins Institute for Clinical and Translational Research’s (ICTR) and the Center for Metabolomics Analysis are hosting a symposium Tuesday, March 14 from 9:30 am-12:00 pm in Owens Auditorium at the Koch Cancer Research Building, 1550 Orleans St.  Event check-in and coffee service begin at 9:00am.  All faculty and staff are encouraged to attend. Keynote speakers include Charles Burant, MD, PhD director of the University of Michigan Nutrition Obesity Research Center (P30) and the Michigan Regional Comprehensive Metabolomics Resource […]

Final Rule: Federal Policy on Protection of Human Subjects (Revisions to the Common Rule)


The U.S. government has published its changes to the regulation known as “The Common Rule” governing Human Subjects Research.  The IRB office is reviewing the new rule and will communicate information about the changes, including statements about what these changes mean for researchers at Johns Hopkins University in the next few months. The rule goes into effect in 2018. For more information: https://www.federalregister.gov/documents/2017/01/19/2017-01058/federal-policy-for-protection-of-human-subjects. http://www.hopkinsmedicine.org/institutional_review_board/  

Funding Opportunity: ATIP Grants, Deadline February 20, 2017


Open to all Johns Hopkins Faculty The milestone-driven Accelerated Translational Incubator Pilot (ATIP) program provides up to $100,000 over twelve months in targeted funding and project management for faculty conducting translational research projects. The ICTR is now requesting applications with a deadline for submission by 11:59 pm on Monday, February 20, 2017.  Any Johns Hopkins University faculty member interested in starting a translational project is eligible to apply, however awarded PIs may not apply for a new ATIP project within the twenty-four months following receipt of their initial award funds.  Grants are for up to $100,000 in direct costs and may not be […]

Funding Opportunity: Johns Hopkins & Kaiser Permanente Research Collaboration Grant


The Kaiser Permanente and Johns Hopkins Medicine Research Collaboration Committee is actively requesting research proposals to foster collaborative research between the two institutions and address complex and intriguing healthcare and clinical questions vexing our health systems.  Specifically, we are looking for research proposals that are aligned with both organizations’ strategies and present opportunities to prove the synergy of the Kaiser Permanente/Johns Hopkins collaboration.  We hope to identify and fund proposals that accomplish seminal research utilizing the unique capabilities that only two such organizations as Kaiser Permanente and Johns Hopkins have. Broadly, the goal is to support collaborative epidemiologic, health services […]

Special Seminar-NEW LOCATION: Kathy Hudson – Proposed Revisions to the Common Rule – October 5


Genome Sequencing Aids in Treatment of Pancreatic Cancer


STUDY ADVANCES POTENTIAL OF TUMOR GENOME SEQUENCING AND DNA-BASED BLOOD TESTS IN PRECISION TREATMENT AND DETECTION OF PANCREATIC CANCER In a genome-sequencing study of pancreatic cancers and blood in 101 patients, Johns Hopkins Kimmel Cancer Center scientists say they found at least one-third of the patients’ tumors have genetic mutations that may someday help guide precision therapy of their disease. Results of blood tests to detect DNA shed from tumors, they say, also predicted cancer recurrence more than half a year earlier than standard imaging methods. “Pancreatic cancer has one of the highest death rates among cancer types. Many people […]

Malaria Immunization


A VACCINE ALTERNATIVE PROTECTS MICE AGAINST MALARIA –Vectored immunoprophylaxis (VIP) injection triggers creation of antibodies that prevent malaria in 70 percent of mice A study led by Johns Hopkins Bloomberg School of Public Health researchers found that injecting a vaccine-like compound into mice was effective in protecting them from malaria. The findings suggest a potential new path toward the elusive goal of malaria immunization. Mice injected with a virus genetically altered to help the rodents create an antibody designed to fight the malaria parasite produced high levels of the anti-malaria antibody. The approach, known as Vector immunoprophylaxis, or VIP, has […]